Marniza Saad

Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer

Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2023 · 319 citations · Full text

Medicine, Oncology, Urology +17

Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial

K.N. Chi, Shahneen Sandhu, Matthew R. Smith et al. · Annals of Oncology · 2023 · 199 citations · Full text

Medicine, Oncology, Urology +17

Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations.

Kim N., Dana E. Rathkopf, Matthew R. Smith et al. · Journal of Clinical Oncology · 2022 · 125 citations

Medicine, Oncology, Pharmacology +16

Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action

Nirmala Bhoo‐Pathy, Chiu‐Wan Ng, Gerard Lim et al. · Journal of Oncology Practice · 2019 · 94 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Impact of adjuvant chemotherapy on survival of women with T1N0M0, hormone receptor negative breast cancer

Nanthini Thevi Bhoo-Pathy, Nanthini Thevi Bhoo-Pathy, Shinako Inaida et al. · Cancer Epidemiology · 2017 · 64 citations

Medicine, Oncology, Breast Oncology +13